Vermilion Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in New Delhi, Delhi, India, established in 2009.
2009 New Delhi, Delhi, India Struck Off
Last Updated:
About Vermilion Pharmaceuticals Private Limited

Vermilion Pharmaceuticals Private Limited, a struck off private limited company, was established on 26 May 2009 in New Delhi, Delhi, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74900DL2009PTC190628. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Archana Singh (Director), Manoj Kumar Singh (Director). Its latest AGM occurred on 30 October 2010, with the balance sheet filed on 31 March 2010. It is based at 320, B-1, Inderjeet Singh Palace Delhi Gate, Main Bazar, New Delhi, Delhi, 110002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74900DL2009PTC190628

  • Registration Number

    190628

  • Incorporation Date

    26 May 2009

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 16 Year, 9 Months
  • Last Filing with ROC 31 Mar 2010
Company report

Vermilion Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Vermilion Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Vermilion Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Archana Singh Director 26 May 2009 Current
Manoj Kumar Singh Director 26 May 2009 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vermilion Pharmaceuticals.

Enhance accessibility to Vermilion Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Vermilion Pharmaceuticals revenue growth over time
Vermilion Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vermilion Pharmaceuticals?

Unlock access to Vermilion Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Vermilion Pharmaceuticals?

Unlock and access historical data on people associated with Vermilion Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vermilion Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vermilion Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vermilion Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Vermilion Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Oct 2010 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Vermilion Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2010 with Roc Delhi. was completed.

  • Director Appointment

    Archana Singh was appointed as a Director was appointed as a Director on 26 May 2009 & has been associated with this company since 16 years 9 months . was recorded as a recent event.

  • Director Appointment

    The activity Manoj Kumar Singh was appointed as a Director was appointed as a Director on 26 May 2009 & has been associated with this company since 16 years 9 months . was completed.

  • Company Incorporation

    The activity Vermilion Pharmaceuticals Private Limited was registered on 26 May 2009 with Roc Delhi & aged 16 years 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Vermilion Pharmaceuticals Private Limited?

The CIN of Vermilion Pharmaceuticals Private Limited is U74900DL2009PTC190628.

Where is Vermilion Pharmaceuticals Private Limited headquartered?

Vermilion Pharmaceuticals Private Limited is headquartered at 320, B-1, Inderjeet Singh Palace Delhi Gate, Main Bazar, New Delhi, Delhi, 110002.

When was Vermilion Pharmaceuticals Private Limited incorporated?

Vermilion Pharmaceuticals Private Limited was incorporated on 26 May 2009.

Who are the current directors of Vermilion Pharmaceuticals Private Limited?

The current directors of Vermilion Pharmaceuticals Private Limited are

What is the primary industry of Vermilion Pharmaceuticals Private Limited?

The primary industry of Vermilion Pharmaceuticals Private Limited is Business Services.

Is Vermilion Pharmaceuticals Private Limited a listed company?

Vermilion Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Vermilion Pharmaceuticals Private Limited?

The authorized capital of Vermilion Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available